NIPT for fetal sexing (X-linked disorders)
Applicable for all labs undertaking NIPT for fetal sexing (X-linked disorders).
Homologous Recombination Deficiency (HRD) testing in ovarian cancer [Tissue]
Applicable to all labs undertaking molecular genetic testing for HRD in solid tumours.
Inherited Retinal Disorders (IRD)
Applicable to all labs undertaking molecular genetic testing for syndromic and non-syndromic IRD.
Lung Cancer (NSCLC) [Plasma]
Applicable for all labs undertaking molecular testing of cfDNA in plasma for EGFR and KRAS gene variants in NSCLC.
Lung cancer (NSCLC) [Tissue]
Applicable to all labs undertaking molecular testing for this cancer type using FFPE tissue.
It is MANDATORY to participate in this EQA scheme for the COMMON BIOMARKERS option, you must also select an item from the Lung New and Emerging biomarkers options. if you do not want to participate select “I do not wish to purchase Lung New and Emerging”
Lynch syndrome (hereditary non-polyposis colon cancer, HNPCC)
Applicable to all labs undertaking molecular genetic testing for this hereditary cancer type.
